Haemonetics Corp. (HAE) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $103.24 +0.31%
EPS Growth %: 0.0%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q1 EPS of $0.38, $0.02 better than the analyst estimate of $0.36. Revenue for the quarter came in at $224.49 million versus the consensus estimate of $215.85 million.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update
- Freeport-McMoRan shares surge as copper hits record $14,694/ton
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
